Hospitalized Covid-19 patients who received transfusions of blood plasma rich with antibodies from recovered patients reduced their mortality rate by about 50%, researchers running a large national study said https://t.co/cFcK8FnSxV

— The Wall Street Journal (@WSJ) August 5, 2020